Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis

OBJECTIVES: This post hoc analysis of the TOZURA study programme evaluated the efficacy and safety of subcutaneous tocilizumab (TCZ-SC) as monotherapy or with concomitant conventional synthetic DMARDs (csDMARDs) in patients with RA categorized by baseline glucocorticoid (GC) use. METHODS: TOZURA was...

Descripción completa

Detalles Bibliográficos
Autores principales: Choy, Ernest, Caporali, Roberto, Xavier, Ricardo, Fautrel, Bruno, Sanmarti, Raimon, Bao, Min, Devenport, Jenny, Pethö-Schramm, Attila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532446/
https://www.ncbi.nlm.nih.gov/pubmed/30649524
http://dx.doi.org/10.1093/rheumatology/key393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532446/
https://www.ncbi.nlm.nih.gov/pubmed/30649524
http://dx.doi.org/10.1093/rheumatology/key393

Ejemplares similares